- Home
- MRUS vs DFH Comparison
MRUS vs DFH Comparison
Compare MRUS & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- DFH
- Stock Information
- Founded
- MRUS 2003
- DFH 2008
- Country
- MRUS Netherlands
- DFH United States
- Employees
- MRUS N/A
- DFH N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- DFH Homebuilding
- Sector
- MRUS Health Care
- DFH Consumer Discretionary
- Exchange
- MRUS Nasdaq
- DFH Nasdaq
- Market Cap
- MRUS 4.1B
- DFH 2.3B
- IPO Year
- MRUS 2016
- DFH 2021
- Fundamental
- Price
- MRUS $54.74
- DFH $28.32
- Analyst Decision
- MRUS Strong Buy
- DFH Hold
- Analyst Count
- MRUS 13
- DFH 1
- Target Price
- MRUS $88.54
- DFH $28.00
- AVG Volume (30 Days)
- MRUS 732.2K
- DFH 492.8K
- Earning Date
- MRUS 07-31-2025
- DFH 07-31-2025
- Dividend Yield
- MRUS N/A
- DFH N/A
- EPS Growth
- MRUS N/A
- DFH 14.93
- EPS
- MRUS N/A
- DFH 3.34
- Revenue
- MRUS $54,732,000.00
- DFH $4,613,677,000.00
- Revenue This Year
- MRUS $75.57
- DFH $7.02
- Revenue Next Year
- MRUS $31.84
- DFH $2.12
- P/E Ratio
- MRUS N/A
- DFH $8.48
- Revenue Growth
- MRUS 42.77
- DFH 21.19
- 52 Week Low
- MRUS $33.19
- DFH $19.65
- 52 Week High
- MRUS $62.98
- DFH $39.15
- Technical
- Relative Strength Index (RSI)
- MRUS 56.79
- DFH 70.87
- Support Level
- MRUS $51.78
- DFH $25.51
- Resistance Level
- MRUS $55.30
- DFH $29.40
- Average True Range (ATR)
- MRUS 1.63
- DFH 1.42
- MACD
- MRUS -0.11
- DFH 0.32
- Stochastic Oscillator
- MRUS 84.09
- DFH 85.71
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.